SCYNEXIS, Inc. Disposal Group, Including Discontinued Operation, Revenue
SCYNEXIS, Inc. (SCYX) reported Disposal Group, Including Discontinued Operation, Revenue of $7.41 million for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-07.
Discontinued › Income Statement › Other Income
us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue · last filed 2016-03-07
- SCYNEXIS, Inc. disposal group, including discontinued operation, revenue for fiscal 2015 was $7.41M, a 58.31% decline from fiscal 2014.
- SCYNEXIS, Inc. disposal group, including discontinued operation, revenue for fiscal 2014 was $17.77M.
| Period end | Disposal Group, Including Discontinued Operation, Revenue 12 month |
|---|---|
| 2015-12-31 | $7.41M 10-K · filed 2016-03-07 |
| 2014-12-31 | $17.77M 10-K · filed 2016-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |